International Society of Liquid Biopsy shared a post on X about a recent article by Shivahamy Maheswaran et al. published in The Journal of Liquid Biopsy:
“ASCO25 Liquid Biopsy Highlights
Liquid biopsy is entering clinical practice
- Plasma-guided chemo in NSCLC
- ctDNA-driven therapy switch in HR+/HER2− BC
- ctDNA-negativity → less axillary surgery?
- Post-op ctDNA = strong prognostic tool in CRC and MIBC
- Multi-omics and Pap-derived cfDNA → future of early detection and risk stratification
But challenges remain: assay heterogeneity, discordant results, and standardization needs.
Full editorial from ISLB Young Committee in The Journal of Liquid Biopsy.”
Title: Cancer in a Drop: Liquid biopsy insights from AACR 2025
Authors: Shivahamy Maheswaran, Roberto Borea, Diego de Miguel Perez, Pasquale Pisapia, Nadia Ghazali, Canio Martinelli, Pavel Stejskal, Carolina Reduzzi
Read the Full Article on The Journal of Liquid Biopsy.
More posts featuring International Society of Liquid Biopsy on OncoDaily.